Mauna Kea Technologies Reports Fourth Quarter and Full Year 2020 Sales
Full year sales decreased 12% year-over-year; U.S. sales up 4% year-over-year
2H 20 total sales up 27% year-over-year
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced sales results for the fourth quarter and twelve months of fiscal year 2020.
Fourth Quarter of 2020 Sales Summary
Total sales for the fourth quarter of 2020 increased €0.7 million, or 41% year-over-year, to €2.4 million
Consumables sales decreased €0.1 million, or 5% year-over-year, to €1.0 million
Systems sales increased €0.7 million, or 192% year-over-year, to €1.1 million
Services sales decreased 2% year-over-year to €0.3 million